Hepatic artery infusion chemotherapy combined with the FOLFOX regimen for the treatment of hepatocellular carcinoma: recent advances and literature review.

Suqi ZhuYahan YuMingqi YangXin LiuMingkai LaiJieren ZhongXiaoguang ZhaoLigong LuYanyan Liu

Published in: Expert review of anticancer therapy (2024)

The combination of HAIC with the FOLFOX regimen can help prevent the low intratumoral accumulation and high adverse reaction rate caused by the FOLFOX alone, holding significant potential in the comprehensive treatment of future HCC patients.

Keyphrases

end stage renal disease
chronic kidney disease
ejection fraction
metastatic colorectal cancer
newly diagnosed
squamous cell carcinoma
prognostic factors
low dose
case report
replacement therapy
rectal cancer
patient reported